Patent ID: 11859200
Assignee: VOYAGER THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 4:
5. The AAV particle of claim 4, wherein the protein is apolipoprotein E (APOE), human survival of motor neuron 1 (SMN1), human survival of motor neuron 2 (SMN2), aromatic L-amino acid decarboxylase (AADC), aspartoacylase (ASPA), tripeptidyl peptidase I, beta-galactosidase, N-sulphoglucosamine sulphohydrolase, N-acetyl-alpha-glucosaminidase (NAGLU), iduronate 2 sulfatase (IDS), intracellular cholesterol transporter (NCP1), or gigaxonin.